DSM is active in nutritional and pharma ingredients, performance materials and industrial chemicals. Its products are used in a wide range of end-markets and applications. DSM's activities are grouped into four clusters: Nutrition, Pharma, Performance Materials and Industrial Chemicals.
DSM's new strategy will focus on accelerated growth and expansion of the specialty content of its portfolio, accelerated innovation, and expansion in emerging economies. The overall objective of the strategy is “strong value creation” by market-driven growth
and innovation, increased presence in emerging economies and operational excellence.
DSM intends to grow its sales in four emerging business areas; personalised nutrition, specialty packaging, biomedical materials and white/industrial biotechnology. It also intends to further grow the specialty content of its portfolio.
The company plans to continue the trend of improving its globally balanced presence by accelerating the internationalisation of its asset base and workforce. DSM has been focussing on China and India and it has also started investigating future possibilities in Russia.
DSM has sales of around Euro9bn and around 22,000 employees (2010) with headquarters in Heelen, The Netherlands.
Key Personnel
Chairman: Feike Sijbesma
Member: Nico Gerardu
Member: Stephan Tanda
Member and CFO: Rolf-Dieter Schwalb
Member: Margo Vliegenthart
Chief innovation officer: Rob van Leen
Chief purchasing officer: Tim Tolhurst
Corporate secretary: Femke Weijtens
Chairman (supervisory board): Rob Routs
Member supervisory board: Pauline van der Meer Mohr
Business group director (Dyneema): Gerard de Reuver
Business unit director (NeoResins): Steve Hartig
Business group director (Resins): Dimitri de Vreeze
Executive VP (CHR): Chris Van Steenbergen
President (Biomedica): Christophe Dardel
Chief marketing officer: Mauricio Adade
Senior vice president (emerging business): Anton Robek
Vice president (strategy and growth): Volkert Claassen
President (human nutrition & health and nutritional products): Rick Greubel
President and CEO (DSM Pharmaceutical Products): Alexander Wessels
President and CEO (DSM Food Specialties): Hans Christian Ambjerg
(Updated May 2011)
Contacts
PO Box 6500
6401 JH Heelen
The Netherlands
Tel: +31 45 578 2422
Fax: +31 45 574 0608
www.dsm.com
DSM
Company Structure
DSM is active in nutritional and pharma ingredients, performance materials and industrial chemicals. DSM’s products are used in a wide range of end-markets and applications, such as human and animal nutrition and health, personal care, pharmaceuticals, automotive and transport, coatings and paints, housing and electrics and electronics.
More about DSM Structure
DSM
Strategy & Financial Highlights
DSM states that after successfully completing its strategy “Vision 2005 Focus and Value” in 2006, it will focus on its five year strategy of “Vision 2010 Building on Strengths” in 2007. The new strategy will focus on accelerated growth and expansion of the specialty content of its portfolio, accelerated innovation, and expansion in emerging economies. The overall objective of the strategy is “strong value creation”. (Edited from: “Message from the chairman”, “Objectives Vision 2010 – Building on Strengths"). ICIS also provides you with key financial data listed in table form.
More about DSM Strategy & Financial Highlights
News:
Get news on DSM plus the latest chemical news, information, data, market movements and analysis
in one place with ICIS news
Search:
Find details on other chemical companies and suppliers with
ICIS search
Newsletters:
ICIS offers a range of FREE e-newsletters to ensure that you don't miss out on the latest development and key market intelligence in your industry. If you want the latest news sent to your inbox, sign up for ICIS e-newsletters today.
Plants and projects:
Find out more about current and planned chemical plants and projects by subscribing to our comprehensive database